2017 Program


Global Cardio-Oncology Summit 2017


For your convenience, you may also print this agenda.


Wednesday, September 20, 2017

7:00 am – 19:30

TimeTopicLocation / Speaker
7:00 - 8:00Breakfast & Registration
8:00 - 8:10Welcome & IntroductionCo-Chairs: Dr. Alexander Lyon & Dr. Susannah Stanway
Session 1
Chairs: Dr. Sarah Clarke & Dr. Susan Dent
8:10 - 8:20Opening AddressDr. Daniel Lenihan
President, ICOS; Cardiologist, Vanderbilt Heart and Vascular Institute, Nashville, TN, USA
8:20 - 8:40Keynote Lecture
Cancer Survivorship and the Impact of Cardiovascular Disease
Prof. Jane Maher
Chief Medical Officer, Macmillan Cancer Support, London, UK
8:40 - 9:00Patient's Perspective
Discussion: 5 minutes
9:00 - 9:20Session 1 Panel Discussion
Session 2: Immunotherapy and Emerging Cardiotoxicity
Chairs: Dr. Juan Carlos Plana & Dr. Ruth Plummer
9:20 - 9:40The Impact of Immunotherapy in Treating Solid TumoursDr. James Larkin
Consultant Medical Oncologist, The Royal Marsden NHS Foundation Trust, London, UK
9:40 - 10:00Cardiotoxicity Caused by ImmunotherapyDr. Javid Moslehi
Director, Vanderbilt Cardio-Oncology, Vanderbilt University Medical Centre, Nashville, TN, USA
10:00 - 10:30Session 2 Case Review & Panel DiscussionTBD
10:30 - 11:00BreakOsler Long Room
Session 3: Hormonal Therapies and Cardiovascular Risk
Chairs: Prof. Theresa McDonagh & Dr. Christine Simmons
11:00 - 11:20Cardiovascular Risk with Chronic Oestrogen Suppression - Is there a risk?Dr. Ann Partridge
Director, Adult Survivorship Program, Dana-Farber Cancer Institute, Boston, MA, USA
11:20 - 11:40Novel Pathophysiology of Cardiovascular Risk with Oestrogen AntagonistsDr. Anne Blaes
Associate Professor of Medicine, University of Minnesota, Minneapolis, MN, USA
11:40 - 12:00Cardiac Outcomes of ADT in Prostate CancerDr. Stuart Rosen
Consultant Cardiologist, Royal Brompton & Harefield NHS Foundation Trust, London, UK
12:00 - 12:30Session 3 Case Review & Panel DiscussionTBD
12:30 - 13:30Lunch

Poster Presentation Session #1
Osler Long Room

Dorchester Library
Plenary Lecture
Chairs: Prof. Helena Earl & Dr. Sanjay Prasad
13:30 - 14:00HER2 Targeted Therapies for Breast Cancer – New Insights and Cardiac Safety Discussion: 5 minutesProf. Ian Smith
Consultant Medical Oncologist, Royal Marsden NHS Foundation Trust, London, UK
Session 4: Radiation Therapy & Long-term Cardiovascular Complications
Chairs: Dr. Mark Harbinson & Dr. Anna Kirby
14:00 - 14:15Radiation-Related Heart Disease: Where are we now?Prof. Sarah Darby
Professor of Medical Statistics, Nuffield Department of Population Health, University of Oxford, Oxford, UK
14:15 - 14:30A Practical Guide to Minimize Radiation-Related CardiotoxicityDr. David Hodgson
Associate Professor of Radiation Oncology, University of Toronto, Toronto, ON, Canada
14:30 - 14:45How to Treat Radiation-Induced Coronary Disease? Prevention & TreatmentDr. Martin Denvir
Consultant Cardiologist, University of Edinburgh, Edinburgh, UK
14:45 - 15:00Radiation-Induced Autonomic Dysfunction and ArrhythmiasDr. John Groarke
Cardio-Oncologist, Dana-Farber Cancer Institute, Boston, MA, USA
15:00 - 15:30Session 4 Case Review & Panel DiscussionCase Presenter: Prof. Jutta Bergler-Klein
Professor of Medicine and Cardiology, Department of Cardiology, Medical University of Vienna, Vienna, Austria
15:30 - 16:00Tea BreakOsler Long Room
Session 5: Coordinating Primary Care in Cardio-Oncology
Chairs: Dr. Ana Barac & Prof. Simon Ray
16:00 - 16:15Raising Awareness of Cardiotoxicity in Primary CareDr. Sinead Clarke
GP Advisor, Macmillan Cancer Support, Nantwich, UK
16:15 - 16:30Managing Cardiovascular Risk in Cancer Patients in Primary CareProf. Michael Kirby
Visiting Professor, University of Hertfordshire, Hertfordshire, UK

Prof. Sara Faithful
Professor of Cancer Nursing Practice, University of Surrey, Surrey, UK
16:30 - 16:45Lessons from Paediatric Oncology – How to Organize Long-Term Cardiovascular Surveillance in Cancer SurvivorsDr. Gill Levitt
Consultant Oncologist, Great Ormond Street for Sick Children NHS Foundation Trust, London, UK
16:45 - 17:00Session 5 Panel Discussion
Plenary Lecture
Chairs: Dr. Christopher Johnson & Dr. Bonnie Ky
17:00 - 17:30Can e-Health Improve Cardio-Oncology Outcomes?
Discussion: 5 minutes
Dr. Karen Syrjala
Co-Director of Survivorship Program, Fred Hutchinson Cancer Research Centre, Seattle, WA, USA
Session 6: Young Investigator Competition
Chair: Dr. Daniel Lenihan
Dr. Daniela Cardinale, Dr. Michael Fradley, Dr. Teresa Lopez-Fernandez, Dr. Sebastian Szmit
17:30 - 17:45A Score to Predict Cardiovascular Disease (CVD) Risk After Early Stage Breast Cancer (ESBC)
5-minute discussion
Dr. Husam Abdel-Qadir
Graduate Student/Cardiologist, University of Toronto, Toronto, ON, Canada
17:45 - 18:00Vascular effects of cisplatin based chemotherapy for testicular cancer (VECTOR) study
5-minute discussion
Dr. Alan Cameron
Clinical Research Fellow, University of Glasgow, Glasgow, United Kingdom
18:00 - 18:15A retrospective single-center cohort study to evaluate trastuzumab-related subclinical cardiotoxicity in patients with HER2-positive breast cancer
5-minute discussion
Dr. Olexiy Aseyev
Clinical Fellow, University of Ottawa, Ottawa, ON, Canada
Special Event & Reception
18:15 - 19:30Special Event
Wine & Cheese Reception

Print Agenda



Global Cardio-Oncology Summit 2017


Thursday, September 21, 2017

7:00 – 17:00

TimeTopicLocation / Speaker
7:30-7:50Breakfast & Registration
7:50-8:00Opening Remarks & Day 1 ReviewCo-Chairs: Dr. Alexander Lyon & Dr. Susannah Stanway
Plenary Lecture
Chairs: Dr. Daniel Lenihan & Dr. Alexander Lyon
8:00 - 8:30Long-Term cardiovascular Outcomes in Survivors of Hodgkin's Lymphoma
Discussion: 5 minutes
Prof. John Radford
Professor in Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK
Session 7: Cardio-Oncology and Haematology-Oncology
Chairs: Dr. Eric Harrison & Dr. Laleh Amiri-Kordestani
8:30 - 8:45How to Manage Cardiac Problems in the Bone Marrow Transplant PatientDr. Charlotte Manisty
Consultant Cardiologist, The Heart Hospital and Barts Health NHS Trust, London, UK
8:45 - 9:00Modern Advances in the Treatment of Cardiac AmyloidDr. Ashutosh Wechalekar
Honorary Consultant Haematologist, Royal Free London NHS Foundation Trust, London, UK
9:00 - 9:15Proteosomal Inhibitors and Cardiac ComplicationsDr. Douglas Sawyer
Chief, Cardiovascular Services, Maine Medical Center, Scarborough, ME, USA
9:15 - 9:30BCR-Abl Inhibitors and Cardiovascular ToxicityDr. Dragana Milojkovic
Consultant Haematologist, Hammersmith Hospital, London, UK
9:30 - 10:00Session 7 Case Review & Panel Discussion

10-minute case presentation
20-minute panel discussion
Case Presenter: TBD
10:00 - 10:30BreakOsler Long Room
Session 8: New Scientific Advances in Cardio-Oncology
Chairs: Prof. Justin Stebbing & Prof. Carlo Gabriele Tocchetti
10:30 - 10:45iPSC Models to Study CardiotoxicityProf. Sian Harding
Professor of Cardiac Pharmacology, National Heart and Lung Institute, Imperial College, London, UK
10:45 - 11:00Novel Insights into Mechanisms of Dexrazoxane-Mediated CardioprotectionDr. Martin Štěrba
Associate Professor and Deputy Head, Department of Pharmacology, Charles University in Prague, Czech Republic
11:00 - 11:15New Strategies to Protect the Heart from Cancer TherapiesProf. Denise Hilfiker-Kleiner
Professor of Molecular Cardiology, Hannover Medical School, Hannover, Germany
11:15 - 11:30TBDTBD
11:30 - 12:00Session 8 Panel Discussion
12:00 - 13:00Lunch

Poster Presentation Session #2
Osler Long Room

Dorchester Library
Plenary Lecture
Chairs: Dr. Susannah Stanway & Dr. Sean Virani
13:00 - 13:30The Global Epidemic of Cancer and Cardiovascular Disease
Discussion: 5 minutes
Prof. Richard Sullivan
Director, Institute of Cancer Policy & Global Health, King's College London, London, UK
Session 9: Arrhythmia management in cancer patients
Chairs: Dr. John-Paul Carpenter & Dr. Kate Newbold
13:30 - 13:50Practical Matters in Atrial Fibrillation - Anticoagulation & Rhythm ManagementDr. Dimitrios Farmakis
Cardiologist, Thalassemia and Transfusion Unit, Ippokrateion General Hospital, Athens, Greece
13:50 - 14:10How and Why to Measure QT and What to do About it?Dr. Chris Plummer
Consultant Cardiologist, The Newcastle upon Tyne Hospital NHS Foundation Trust, Newcastle upon Tyne, UK
14:10 - 14:30How to Manage Patients with Cardiac Pacemakers or Defibrillators Undergoing Cancer Surgery or Thoracic Radiotherapy?Dr. Jay Wright
Lead Clinician for Heart Failure and Cardiac Devices, Liverpool Heart and Chest Hospital NHS Foundation Trust, Liverpool, UK
14:30 - 15:00Session 9 Case Review & Panel DiscussionCase Presenter: TBD
15:00 - 15:30Tea Break
Session 10: How to Deliver a Successful Cardio-Oncology Service
Chairs: Dr. Rod Skinner & Prof. Thomas Suter
15:30 - 15:45Toolkit for Success - Real World OptionsDr. Joerg Herrmann
Cardiologist, Mayo Clinic, Rochester, MN, USA
15:45 - 16:00The Role of the Clinical Nurse Specialist in Cardio-OncologyVicki Chambers
Clinical Nurse Specialist Heart Failure, Royal Brompton & Harefield NHS Foundation Trust, London, UK
16:00 - 16:15Physician Training in Cardio-OncologyDr. John McGowan
Hon. Cardiology Research Fellow, University College London Hatter Cardiovascular Institute, London, UK
16:15 - 16:30How Should we Measure the Quality of a Cardio-Oncology Service?Dr. Ronald Witteles
Associate Professor of Medicine, Stanford University Medical Centre, Stanford, CA, USA
16:30 - 16:50Session 10 Panel Discussion
16:50 - 17:00Closing StatementsCo-Chairs: Alexander Lyon
& Susannah Stanway

Print Agenda